Diagnóstico y tratamiento | 10 FEB 14

Hiperhidrosis

Actualización sobre la identificación y manejo apropiado de la hiperhidrosis, su tratamiento y cuándo derivar a un especialista.
Autor/a: Dres. R. A. Benson, R. Palin, P. J. E. Holt, I. M. Loftus BMJ 2013;347:f6800
INDICE:  1.  | 2. Referencias
Referencias

1 Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg 2007;33:S69-75.
2 Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004;51:241-8.
3 Flanagan KH, Glaser DA. An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis. J Drugs Dermatol 2009;8:477-80.
4 Huang Y-H, Yang C-H, Chen Y-H, Chen C-H, Lee S-H. Reduction in osmidrosis using a suction-assisted cartilage shaver improves the quality of life. Dermatol Surg 2010;36:1573-7.
5 Lee D, Cho S, Kim YC, Park JH, Lee SS, Park SW. Tumescent liposuction with dermal curettage for treatment of axillary osmidrosis and hyperhidrosis. Dermatol Surg2006;32:505-11; discussion 511.
6 Shams K, Rzany BJ, Prescott LE, Musekiwa A. Interventions for excessive sweating of unknown cause (Protocol). John Wiley & Sons, 2011.
7 Schlereth T, Dieterich M, Birklein F. Hyperhidrosis—causes and treatment of enhanced sweating. Dtsch Arztebl Int  009;106:32-7.
8 Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg 1977;186:34-41.
9 Lonsdale-Eccles A, Leonard N, Lawrence C. Axillary hyperhidrosis: eccrine or apocrine? Clin Exp Dermatol 2003;28:2-7.
10 Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg 2002;35:382.
11 Bellet JS. Diagnosis and treatment of primary focal hyperhidrosis in children and adolescents. Semin Cutan Med Surg 2010;29:121-6.
12 Sato K, Leidal R, Sato F. Morphology and development of an apoeccrine sweat gland in human axillae. Am J Physiol 1987;252:R166-80.
13 Amini M, Harmsze AM, Tupker RA. Patient’s estimation of efficacy of various hyperhidrosis treatments in a dermatological clinic. Acta Derm Venereol 2008;88:356-62.
14 Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol 2003;22:40-4.
15 Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004;51:274-86.
16 Swinehart JM. Treatment of axillary hyperhidrosis. Dermatol Surg 2000;26:392-6.
17 Solish N, Bertucci V, Dansereau A, Chih-Ho Hong H, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 2007;33:908-23.
18 Finlay A, Khan G. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
19 Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The dermatology life quality index 1994-2007: a comprehensive review of validation data and clinical  results. Br J Dermatol 2008;159:997-1035.
20 Cetindag I, Boley T, Webb K, Hazelrigg S. Long-term results and quality-of-life measures in the management of hyperhidrosis. Thorac Surg Clin 2008;18:217-22.
21 National Institute for Health and Care Excellence. Hyperhidrosis. Clinical knowledge summary. http://cks.nice.org.uk/hyperhidrosis#!scenario.
22 NHS Choices. Treating hyperhidrosis. www.nhs.uk/Conditions/Hyperhidrosis/Pages/Treatment.aspx.
23 Excessive sweating (hyperhidrosis). Patient.co.uk. www.patient.co.uk/health/excessivesweating-hyperhidrosis.
24 Streker M, Reuther T, Hagen L, Kerscher M. Hyperhidrosis plantaris—a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride. J Dtsch Dermatol Ges 2012;10:115-9.
25 Kim WO, Kil HK, Yoon KB, Yoon DM. Topical glycopyrrolate for patients with facial hyperhidrosis. Br J Dermatol 2008;158:1094-7.
26 Mackenzie A, Burns C, Kavanagh G. Topical glycopyrrolate for axillary hyperhidrosis. Br J Dermatol 2013;169:483-4.
27 Roustit M, Blaise S, Cracowski JL. Trials and tribulations of skin iontophoresis in therapeutics. Br J Clin Pharmacol 2013; published online 16 Apr.
28 Hoorens I, Ongenae K. Primary focal hyperhidrosis: current treatment options and a step-by-step approach. J Eur Acad Dermatol Venereol 2012;26:1-8.
29 McAleer MA, Collins P. A study investigating patients’ experience of hospital and home iontophoresis for hyperhidrosis. J Dermatol Treat 2013; published online 6 May.
30 Kavanagh GM,and Shams K. Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis. J Am Acad Dermatol 2006;55 (suppl 5):S115-7.
31 Davarian S, Kalantari KK, Rezasoltani A, Rahimi A. Effect and  persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis. Australas J Dermatol2008;49:75-9.
32 Dolianitis C, Scarff CE, Kelly J, Sinclair R. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Australas J Dermatol 2004;45:208-12.
33 Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine. J Am Acad Dermatol 2012;66:387-92.
34 Wolosker N, Milanez de Campos JR, Kauffman P, Yazbek G, Neves S, Puech-Leao P. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol 2013;52:620-3.
35 Wolosker N, de Campos JRM, Kauffman P, Puech-Leão P. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg 2012;55:1696-700.
36 Bajaj V, Langtry JA. Use of oral glycopyrronium bromide in hyperhidrosis. Br J Dermatol 2007;157:118-21.
37 Hund M, Sinkgraven R, Rzany B. Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis. J Dtsch Dermatol Ges 2004;2:343-9.
38 Müller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, et  al Efficacy and safety of methantheline bromide (Vagantin(®)) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol 2012;27:1278-84.
39 Naumann MK, Hamm H, Lowe NJ; Botox Hyperhidrosis Clinical Study Group. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 2002;8:247-52.
40 Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo  ontrolled trial. BMJ 2001;323:596-9.
41 Doft MA, Hardy KL, Ascherman JA. Treatment of hyperhidrosis with botulinum toxin. Aesthet Surg J 2012;32:238-44.
42 Vorkamp T, Foo FJ, Khan S, Schmitto JD, Wilson P. Hyperhidrosis: evolving concepts and a comprehensive review. Surgeon 2010;8:287-92.
43 Grunfeld A, Murray CA, Solish N. Botulinum toxin for hyperhidrosis: a review. Am J Clin Dermatol 2009;10:87-102.
44 Gregoriou S, Rigopoulos D, Makris M, Liakou A, Agiosofitou E, Stefanaki C, et al. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production. Dermatol Surg 2010;36:496-8.
45 Lakraj AD, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel) 2013;5:821-40.
46 Talarico-Filho S, Mendonça DO Nascimento M, Sperandeo DE Macedo F, DE Sanctis Pecora C. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg 2007;33:S44-50.
47 Dressler D. Comparing Botox and Xeomin for axillar hyperhidrosis. J Neural Transm 2010;117:317-9.
48 Frasson E, Brigo F, Acler M, Didonè G, Vicentini S, Bertolasi L. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Arch Dermatol 2011;147:2010-1.
49 Rosell K, Hymnelius K, Swartling C. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol 2013;93:335-9.
50 Güleç AT. Dilution of botulinum toxin A in lidocaine vs in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study. J Eur Acad Dermatol Venereol 2012;26:314-8.
51 Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol 2007;156:986-9.
52 Kontochristopoulos G, Gregoriou S, Zakopoulou N, Rigopoulos D. Cryoanalgesia with dichlorotetrafluoroethane spray versus ice packs in patients treated with botulinum toxin-a for palmar hyperhidrosis: self-controlled study. Dermatol Surg 2006;32:873-4.
53 Hayton MJ, Stanley JK, Lowe NJ. A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis. Br J Dermatol 2003;149:447-51.
54 Glass GE, Hussain M, Fleming AN, Powell BW. Atrophy of the intrinsic musculature of the hands associated with the use of botulinum toxin-A injections for hyperhidrosis: a case report and review of the literature. J Plast Reconstr Aesthet Surg 2009;62:e274-6.
55 Moreau MS, Cauhepe C, Magues JP, Senardimonetta JM. A double blind, randomized, comparative study of Dysport® vs Botox® in primary palmar hyperhidrosis. Br J Dermatol 2003;149:1041-5.
56 Askari A, Kordzadeh A, Lee GH, Harvey M. Endoscopic thoracic sympathectomy for primary hyperhidrosis: a 16-year follow up in a single UK centre. Surgeon 2013;11:130-3.
57 Plas EG, Függer R, Herbst F, Fritsch A. Complications of endoscopic thoracic sympathectomy. Surgery 1995;118:493-5.
58 Cerfolio RJ, Milanez De Campos JR, Bryant A, Connery CP, Miller DL, DeCamp MM, et al. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg 2011;91:1642-8.
59 Guimarães PSF, Coelho M, Mendes RG, Caetano da Silva RFK, Fernandes LM, Cecilio WAC. Ramicotomy in association with endoscopic sympathetic blockade in the treatment of axillary hyperhidrosis. Surg Laparosc Endosc Percutan Tech 2013;23:223-8.
60 Dewey TM, Herbert MA, Hill SL, Prince SL, Mack MJ. One-year follow-up after thoracoscopic sympathectomy for hyperhidrosis: outcomes and consequences. Ann Thorac Surg 2006;81:1227-32; discussion 1232-3.
61 Henteleff H, Kalavrouziotis D. Evidence-based review of the surgical management of hyperhidrosis. Thorac Surg Clin 2008;18:209-16.
62 Deng B, Tan QY, Jiang YG, Zhao YP, Zhou JH, Ma Z, et al. Optimization of sympathectomy to treat palmar hyperhidrosis: the systematic review and meta-analysis of studies published during the past decade. Surg Endosc 2011;25:1893-901.
63 Li Y, Li W, Lv X, Li X. A refined minimally invasive procedure for radical treatment of axillary osmidrosis: combined tumescent liposuction with subcutaneous pruning through a small incision. J Plast Reconstr Aesthet Surg 2012;65:e320-1.
64 Arneja JS, Hayakawa TEJ, Singh GB, Murray KA, Turner RB, Ross LL, et al. Axillary hyperhidrosis: a 5-year review of treatment efficacy and recurrence rates using a new arthroscopic shaver technique. Plast Reconstr Surg 2007;119:562-7.
65 Ibrahim O, Kakar R, Bolotin D, Nodzenski M, Disphanurat W, Pace N, et al. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial. J Am Acad Dermatol 2013;69:88-95.
66 Bechara FG, Georgas D, Sand M, Stucker M, Othlinghaus N, Altmeyer P, et al. Effects of a long-pulsed 800-nm diode laser on axillary hyperhidrosis: a randomized controlled half-side comparison study. Dermatol Surg 2012;38:736-40. Accepted: 04 November 2013
 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022